Polydrug use

Most substance use information treats drugs as discrete categories. There are articles about alcohol, articles about cocaine, articles about benzodiazepines. What is much rarer is honest, practical information about what happens when you combine them , which is what most people who use any of these substances actually do.

The data is clear: polydrug use is the norm rather than the exception. The National Drug Strategy Household Survey consistently finds that Australians who use illicit drugs typically use multiple substances, and that alcohol is present in the large majority of polydrug use occasions. Understanding the interactions is not an academic exercise , it's directly relevant to the actual risk profile of the way most people use.

Alcohol and cocaine: cocaethylene

This is probably the most common polydrug combination in Australia's urban recreational environment, and it has a specific pharmacological interaction that most people using both together have not heard of.

When alcohol and cocaine are consumed together, the liver produces a third compound: cocaethylene. Cocaethylene has its own psychoactive profile , similar to cocaine but with a longer half-life , and it is significantly more cardiotoxic than either alcohol or cocaine alone.

Research published in Forensic Science International and elsewhere has found that cocaethylene substantially increases the strain on cardiac tissue, and that a significant proportion of cocaine-associated cardiac events occur in the presence of alcohol. The combination also appears to extend the subjective cocaine effect , partly why people who are drinking are more likely to seek out cocaine or to use more of it.

The interaction also complicates the mental health picture. The cocaine comedown is already significant on its own. Combined with alcohol's own rebound anxiety and sleep disruption, the Monday and Tuesday after a cocaine-and-alcohol weekend carries a pharmacological weight that is considerably greater than either substance alone.

Alcohol and benzodiazepines: additive CNS depression

Both alcohol and benzodiazepines depress central nervous system activity through GABAergic mechanisms. Their combined effect is not simply additive , it is potentially synergistic, producing sedation and respiratory depression substantially greater than either substance alone at the same doses.

This interaction is the basis of the absolute contraindication on benzodiazepine packaging against concurrent alcohol use. It is also, in practice, frequently violated , by people who have been prescribed benzodiazepines for anxiety or sleep, who also drink, and who do not clearly understand that the combination is not simply "a stronger sedative effect" but a qualitatively different and potentially dangerous one.

For people taking prescribed benzodiazepines , or managing a taper, as described in benzos and the prescription that became a habit , the interaction with alcohol is a clinically significant risk worth taking seriously.

Alcohol and opioids: the same problem

The alcohol-opioid combination carries the same risk as alcohol-benzodiazepine: additive CNS depression with respiratory consequences. The majority of opioid overdose deaths involve concurrent alcohol or benzodiazepine use. This is not a combination for which there is a "careful" dose , the interaction is pharmacologically unpredictable enough that the safest approach is avoidance.

For people managing prescribed opioids for pain alongside social drinking , a common situation , this risk is worth an explicit and honest conversation with a prescribing GP.

MDMA and stimulants: cardiovascular load

MDMA combined with other stimulants , cocaine, amphetamines, or caffeine at high doses , produces additive cardiovascular effects. Elevated heart rate, blood pressure, and body temperature are all exacerbated by stimulant combinations. The thermoregulation concern is particularly relevant in warm environments or when dancing , hyperthermia is one of the primary mechanisms of acute MDMA-related harm, and adding another stimulant to the picture raises that risk.

MDMA and cocaine are sometimes combined at events; the pharmacological rationale from the user's perspective is that cocaine supplements the stimulant effects when the MDMA begins to diminish. The cardiovascular consequence is a cumulative load that is considerably more significant than either substance at the same doses individually.

Cannabis and stimulants: the paranoia accelerator

Cannabis combined with stimulants , particularly methamphetamine, but also cocaine and MDMA , has a well-documented interaction with anxiety and paranoia. Stimulants already increase anxiety at a neurochemical level; cannabis, particularly high-THC cannabis at the doses now common in the Australian market, has its own anxiogenic effects in a significant proportion of users.

The combination is frequently reported in the context of methamphetamine-induced psychosis presentations. Cannabis does not cause methamphetamine psychosis directly, but it appears to lower the threshold for paranoid ideation and to amplify existing stimulant anxiety. Daily cannabis use combined with stimulant use is a combination worth examining carefully if the user has noticed increasing anxiety, paranoia, or difficulty distinguishing normal social interpretation from threat.

Cannabis and alcohol: the spin

The combination is extremely common and generally low-risk for most people at moderate doses. The specific interaction worth noting is the dramatically increased risk of acute nausea and vomiting ("the spin" or "whitey") when cannabis is consumed after alcohol rather than before. The mechanism is not fully established; the clinical recommendation, if harm reduction is the goal, is cannabis before alcohol rather than after, and not on an empty stomach.

Tracking your own combinations

The reason polydrug use is underaddressed in self-monitoring is that most tracking tools , and most self-report , focus on one substance at a time. But the relevant unit for understanding your own risk and functional picture may be the combination and the occasion rather than any individual substance.

Tracking alcohol, cannabis, and cocaine use as separate entries in the same session, alongside mood and sleep in the subsequent days, gives you a more complete picture of what the combined experience is costing you than any single-substance diary can.

---

See also: what is harm reduction? for context on the philosophy behind accurate information over abstinence messaging.

ayodee can track multiple substances in the same session alongside mood and wellbeing data. Anonymous. No email. ayodee.app.